Skip to main content
. 2026 Feb 14;14(4):486. doi: 10.3390/healthcare14040486
HCV hepatitis C virus
DAA direct-acting antiviral
SVR sustained virological response
LDL-C low-density lipoprotein cholesterol
HDL-C high-density lipoprotein cholesterol
BMI body mass index
APRI aspartate aminotransferase-to-platelet ratio index
FIB-4 fibrosis-4 index
CI confidence interval
GLE/PIB glecaprevir/pibrentasvir
LDV/SOF ledipasvir/sofosbuvir
OMB/PAR/RIT + DAS ombitasvir/paritaprevir/ritonavir + dasabuvir
SOF/VEL sofosbuvir/velpatasvir
HCC hepatocellular carcinoma